MLMC Therapeutics ApS is a Danish APS based in Kastrup, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company reported revenue of -30,8 t kr. in its latest annual filing.
Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er forskning i og udvikling af teknologi til produktion af oral medicin, samt aktiviteter, som efter ledelsens skøn naturligt står i forbindelse hermed.
In its most recent annual report (2025), MLMC Therapeutics ApS reported a gross profit of -30,8 t kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 144,2 t kr..
